ALS risk
novel ALS mutations
ALS genomic modifiers
ALS-associated brain morphology
genetic data
strong genetic factors
environmental factors
genetic counselling
exact genetic contribution
clinical pleiotropic features
causal mutations
modifiers of C9orf72 mutations
specific pleiotropic clinical features
variable clinical expressivity
clinical trial design
small effect factors
low-frequency genetic variants
complex contribution of thousands
disproportionate large contribution
brain gene-expression patterns
important step
cellular models
new opportunities
Genomic findings
mutation interaction
life time risk
new research fields
Emerging Simplex ORigins
unbiased drug screens
development of cellular reporter assays
novel machine learning algorithms
Imaging genomics overlays patterns
MRI
patients
blood epigenetic profiles
three-dimensional folding ofÂ DNA
aim
reduced penetrance
monogenetic cause
CRISPR-Cas9
clear impact
lethal disease
Amyotrophic Lateral Sclerosis
lumping
diagnostic continuum
collection of unique rare diseases
order
art
biological heterogeneity
urgent unmet therapeutic need
ERC
state
approaches
scope
play
phenomena